GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (GREY:DCOIF) » Definitions » Buildings And Improvements

Dicot AB (Dicot AB) Buildings And Improvements : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Dicot AB Buildings And Improvements?


Dicot AB Buildings And Improvements Historical Data

The historical data trend for Dicot AB's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Buildings And Improvements Chart

Dicot AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buildings And Improvements
Get a 7-Day Free Trial - - - - -

Dicot AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dicot AB Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Dicot AB (Dicot AB) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (Dicot AB) Headlines

No Headlines